Are you Dr. Jacobson-Dunlop?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 20 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3800 Park Nicollet Blvd
Saint Louis Park, MN 55416Phone+1 952-993-3123
Summary
- Dr. Erick Jacobson-Dunlop, MD is a board certified pathologist in Saint Louis Park, Minnesota. He is currently licensed to practice medicine in Minnesota, Colorado, and Missouri. He is affiliated with Minneapolis VA Medical Center.
Education & Training
- SUNY Downstate Health Sciences UniversityFellowship, Dermatopathology, 2013 - 2014
- Oregon Health & Science University (OHSU Health)Residency, Pathology-Anatomic and Clinical, 2009 - 2013
- Oregon Health and Science University School of MedicineClass of 2009
Certifications & Licensure
- MN State Medical License 2014 - 2025
- MT State Medical License 2020 - 2024
- CO State Medical License 2020 - 2023
- IA State Medical License 2014 - 2023
- IN State Medical License 2014 - 2023
- MO State Medical License 2020 - 2023
- NV State Medical License 2016 - 2023
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Dermatopathology
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsStevens-Johnson syndrome precipitated by Moderna Inc. COVID-19 vaccine: a case-based review of literature comparing vaccine and drug-induced Stevens-Johnson syndrome/t...Jessica J Padniewski, Erick Jacobson-Dunlop, Sam Albadri, Sara Hylwa
International Journal of Dermatology. 2022-08-01 - Intravascular pseudolymphomatous angiosarcoma: A new finding potentially mistaken for intravascular lymphoma.Amrita Goyal, Whitney Tope, Whitney Tope, Paari Murugan, Erick Jacobson-Dunlop
Journal of Cutaneous Pathology. 2021-04-25 - 4 citationsAcquired epidermodysplasia verruciformis in setting of tumor necrosis factor-α inhibitor therapyBrittney Schultz, Cuong V. Nguyen, Erick Jacobson-Dunlop
JAAD Case Reports. 2018-09-01